CorMedix (CRMD) FCF Margin (2015 - 2025)

CorMedix's (CRMD) quarterly FCF Margin came in at 72.11% in Q4 2025, up 9013.0% year-on-year from 0.79% in Q4 2024, and up 147.74% quarter-over-quarter from 29.11% in Q3 2025.

CorMedix (CRMD) FCF Margin (2015 - 2025) Analysis & Trends

CorMedix has disclosed FCF Margin across 10 years of filings, most recently posting 72.11% for Q4 2025.

  • FCF Margin for Q4 2025 came in at 72.11%, up 9013.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 55.43% (up 17205.0% YoY), and the FY2025 annual result was 55.43%, up 17213.0% from the prior year.
  • FCF Margin came in at 72.11% for Q4 2025 at CorMedix, up from 29.11% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 75.42% in Q2 2025 to a low of 89069.3% in Q3 2022.
  • The 4-year median for FCF Margin is 7595.53% (2021), against an average of 19961.88%.
  • Peak annual rise in FCF Margin reached 1206455 bps in 2022, while the deepest fall reached 8078407 bps in 2022.
  • CorMedix's FCF Margin stood at 11522.1% in 2021, then sank by 84 bps to 21155.46% in 2022, then soared by 100 bps to 18.02% in 2024, then soared by 500 bps to 72.11% in 2025.
  • The last three FCF Margin figures came in at 72.11% (Q4 2025), 29.11% (Q3 2025), and 75.42% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -3.98%
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 43.35%
9 Abivax 91.71 Bn 91.71 Bn - -
10 CorMedix 631,378.03 -154.57 Mn 107.31 Mn 72.11%

Historic Data

Download Data
DateValue
Dec 31, 2025 72.11%
Sep 30, 2025 29.11%
Jun 30, 2025 75.42%
Mar 31, 2025 50.47%
Dec 31, 2024 -18.02%
Sep 30, 2024 -119.23%
Jun 30, 2024 -1,745.98%
Dec 31, 2022 -21,155.46%
Sep 30, 2022 -89,069.30%
Jun 30, 2022 -25,746.85%
Mar 31, 2022 -88,379.60%
Dec 31, 2021 -11,522.10%
Sep 30, 2021 -16,491.83%
Jun 30, 2021 -37,811.40%
Mar 31, 2021 -7,595.53%
Dec 31, 2020 -10,788.26%
Sep 30, 2020 -7,884.82%
Jun 30, 2020 -4,612.33%
Mar 31, 2020 -10,771.66%
Dec 31, 2019 -15,716.10%